How should we diagnose and manage photosensitivity?

1 Fitzpatrick TB. Ultraviolet-induced pigmentary changes: benefits and hazards. Curr Probl Derm 1986; 15: 25–38.

2 Kerr AC Muller F Ferguson J , Occupational carprofen photoallergic contact dermatitis. Br J Dermatol 2008; 159: 1303–8. http://dx.doi.org/10.1111/j.1365-2133.2008.08847.x

3 Stafford R Farrar MD Kift R The impact of photosensitivity disorders on aspects of lifestyle. Br J Dermatol 2010; 163: 817–22. http://dx.doi.org/10.1111/j.1365-2133.2010.09905.x

4 Jong CT Finlay AY Pearse AD The quality of life of 790 patients with photodermatoses. Br J Dermatol 2008; 159: 192–7. http://dx.doi.org/10.1111/j.1365-2133.2008.08581.x

5 Richards HL Ling TC Evangelou G Evidence of high levels of anxiety and depression in polymorphic light eruption and their association with clinical and demographic variables. Br J Dermatol 2008; 159: 439–44. http://dx.doi.org/10.1111/j.1365-2133.2008.08623.x

6 Rizwan M Reddick CL Bundy C Photodermatoses: environmentally induced conditions with high psychological impact. Photochem Photobiol Sci 2013; 12: 182–9. http://dx.doi.org/10.1039/c2pp25177a

7The European Multicentre Photopatch Test Study (EMCPPTS) Taskforce. A European multicentre photopatch test study. Br J Dermatol 2012; 166: 1002–9. http:dx.doi.org/10.1111/j.1365-2133.2012.10857.x

8 Fenton L Dawe R Ibbotson S Impact assessment of energyefficient lighting in patients with lupus erythematosus: a pilot study. Br J Dermatol 2014; 170: 694–8. http://dx.doi.org/10.1111/bjd.12719

9 Moseley H Ferguson J. The risk to normal and photosensitive individuals from exposure to light from compact fluorescent lamps. Photodermatol Photoimmunol Photomed 2011; 27: 131–7. http://dx.doi.org/10.1111/j.1600-0781.2011.00576.x

10 Fenton L Ferguson J Ibbotson S Energy saving lamps and their impact on photosensitive and normal individuals. Br J Dermatol 2013; 169: 910–5. http://dx.doi.org/10.1111/bjd.12457

11 Rhodes LE Bock M Janssens AS Polymorphic light eruption occurs in 18% of Europeans and does not show higher prevalence with increasing latitude: multicenter survey of 6,895 individuals residing from the Mediterranean to Scandinavia. J Invest Dermatol 2010; 130: 626–8. http://dx.doi.org/10.1038/jid.2009.250

12 Lembo S Fallon J O’Kelly P Polymorphic light eruption and skin cancer prevalence: is one protective against the other? Br J Dermatol 2008; 159: 1342–7. http://dx.doi.org/10.1111/j.1365-2133.2008.08734.x

13 O’Gorman SM Murphy GM. Photosensitizing medications and photocarcinogenesis. Photodermatol Photoimmunol Photomed 2014; 30: 8–14. http://dx.doi.org/10.1111/phpp.12085